Back

Plasma lipid signatures in recent-onset dilated cardiomyopathy: a targeted lipidomics study

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Improving understanding of disease in dilated cardiomyopathy Dilated Cardiomyopathy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Yingjing Xie

(China)

6 More presentations in this session

Presentation thumbnail
Systematic assessment of DSP missense variants in a cohort of patients with left ventricular cardiomyopathy
Mr M. Bergier (Buenos Aires, AR)
Abstract
Presentation thumbnail
Genotype influences the risk and age of onset of atrial fibrillation in patients with dilated cardiomyopathy
Doctor D. Cannie (London, GB)
Abstract
Presentation thumbnail
Lysosome-related biomarkers LUM and SERPINA3 for dilated cardiomyopathy: a diagnostic signature linked to immune-cell infiltration
Doctor Z. Li (Tianjin, CN)
Abstract
Presentation thumbnail
Genetic variant spectrum in dilated and non-dilated left ventricular cardiomyopathy
Doctor S. Khoury (Tel Aviv, IL)
Abstract
Presentation thumbnail
Dilated cardiomyopathy: does the right ventricle have an impact on prognostic outcomes?
Doctor J. Faria (Braga, PT)
Abstract

Access the full session

Session thumbnail
Improving understanding of disease in dilated cardiomyopathy

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Lipidomic, plasma and flow cytometry signatures enhance the classification of patients with advanced CVD and CKM syndrome
1 September 2025
thumbnail
Congress Presentation
Myocardial remodelling and left ventricular recovery after guideline-directed medical therapy in non-ischaemic dilated cardiomyopathy
12 December 2024
thumbnail
Congress Presentation
Heart failure and energy metabolism: the role of fatty acid transport proteins and cardiac lipotoxicity
29 June 2021
thumbnail
Congress Presentation
Metabolic profiling in new on-set non-ischemic dilated cardiomyopathy
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources